skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines travoprostQuestion & answer

travoprost · Medicine question

How common is eye redness in clinical trials of Travatan (travoprost)?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Eye redness (ocular hyperaemia) occurred in approximately 20% of patients in clinical trials of Travatan (travoprost).

Sources for this answer

TRAVATAN 40 micrograms/mL eye drops, solutionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 22Document updated 6 February 2023

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about travoprost

How can contamination of the bottle tip and solution be prevented when using Travatan (travoprost) eye drops?Which excipients in Travatan (travoprost) can cause skin irritation or skin reactions?Which preservative does Travatan (travoprost) contain, and how much is present per mL?Can travoprost be used during pregnancy?How soon does travoprost start lowering eye pressure, and when does it reach its maximum effect?Is travoprost recommended during breastfeeding?

travoprost

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the travoprost guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX